share_log

堃博医疗-B(02216)获多名高管持续增持

Bo Medical-B (02216) has been continuously increased by a number of senior executives.

智通財經 ·  Dec 15, 2021 21:56

Zhitong Financial APP was informed that the latest equity information of HKEx shows that following the increase of Mr. Zhao Yiwei, Chairman of the HKEx, Mr. Li Zhenjun, non-Executive Director of Bombo Medical-B (02216), purchased shares of the company from the open market at an average price of HK $8.48per share, resulting in a total increase of 46000 shares, which deserves the continuous attention of investors.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment